20 ‑Valent Pneumococcal Conjugate Vaccine: Pediatric First Approval
This article summarizes the milestones in the development of PCV20 leading to this first pediatric approval for active immunization for the prevention of IPD and otitis media caused by S. pneumoniae.PMID:37440125 | DOI:10.1007/s40272-023-00584-9
Source: Paediatric Drugs - Category: Pediatrics Authors: Matt Shirley Source Type: research
More News: Meningitis Vaccine | Otitis | Otitis Media | Pediatrics | Pfizer | Pneomococcal Vaccine | Pneumonia | Vaccines